The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global OTC Skin Medicine Market Research Report 2025
Synopsis
The global OTC Skin Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for OTC Skin Medicine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for OTC Skin Medicine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of OTC Skin Medicine include Bayer, GSK, Teva, Johnson & Johnson, Novartis, Viatris, Sun Pharmaceutical, China Resources Sanjiu Pharmaceutical and HAPHARM GROUP, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for OTC Skin Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Skin Medicine.
Report Scope
The OTC Skin Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global OTC Skin Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OTC Skin Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
GSK
Teva
Johnson & Johnson
Novartis
Viatris
Sun Pharmaceutical
China Resources Sanjiu Pharmaceutical
HAPHARM GROUP
Zhejiang DND PHARMACEUTICAL
Winsun
Dinuo Pharmaceutical
Guizhou Finder Phar maceutical
Nanjing Cuccess Pharmaceutical
Segment by Type
Oral
Topical
Segment by Application
Hospital
Drug Store
Online Supermarket
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of OTC Skin Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of OTC Skin Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global OTC Skin Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for OTC Skin Medicine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for OTC Skin Medicine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of OTC Skin Medicine include Bayer, GSK, Teva, Johnson & Johnson, Novartis, Viatris, Sun Pharmaceutical, China Resources Sanjiu Pharmaceutical and HAPHARM GROUP, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for OTC Skin Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Skin Medicine.
Report Scope
The OTC Skin Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global OTC Skin Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OTC Skin Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
GSK
Teva
Johnson & Johnson
Novartis
Viatris
Sun Pharmaceutical
China Resources Sanjiu Pharmaceutical
HAPHARM GROUP
Zhejiang DND PHARMACEUTICAL
Winsun
Dinuo Pharmaceutical
Guizhou Finder Phar maceutical
Nanjing Cuccess Pharmaceutical
Segment by Type
Oral
Topical
Segment by Application
Hospital
Drug Store
Online Supermarket
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of OTC Skin Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of OTC Skin Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 OTC Skin Medicine Market Overview
1.1 Product Overview and Scope of OTC Skin Medicine
1.2 OTC Skin Medicine Segment by Type
1.2.1 Global OTC Skin Medicine Market Value Comparison by Type (2024-2030)
1.2.2 Oral
1.2.3 Topical
1.3 OTC Skin Medicine Segment by Application
1.3.1 Global OTC Skin Medicine Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Online Supermarket
1.3.5 Others
1.4 Global OTC Skin Medicine Market Size Estimates and Forecasts
1.4.1 Global OTC Skin Medicine Revenue 2019-2030
1.4.2 Global OTC Skin Medicine Sales 2019-2030
1.4.3 Global OTC Skin Medicine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 OTC Skin Medicine Market Competition by Manufacturers
2.1 Global OTC Skin Medicine Sales Market Share by Manufacturers (2019-2024)
2.2 Global OTC Skin Medicine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global OTC Skin Medicine Average Price by Manufacturers (2019-2024)
2.4 Global OTC Skin Medicine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of OTC Skin Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of OTC Skin Medicine, Product Type & Application
2.7 OTC Skin Medicine Market Competitive Situation and Trends
2.7.1 OTC Skin Medicine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest OTC Skin Medicine Players Market Share by Revenue
2.7.3 Global OTC Skin Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 OTC Skin Medicine Retrospective Market Scenario by Region
3.1 Global OTC Skin Medicine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global OTC Skin Medicine Global OTC Skin Medicine Sales by Region: 2019-2030
3.2.1 Global OTC Skin Medicine Sales by Region: 2019-2024
3.2.2 Global OTC Skin Medicine Sales by Region: 2025-2030
3.3 Global OTC Skin Medicine Global OTC Skin Medicine Revenue by Region: 2019-2030
3.3.1 Global OTC Skin Medicine Revenue by Region: 2019-2024
3.3.2 Global OTC Skin Medicine Revenue by Region: 2025-2030
3.4 North America OTC Skin Medicine Market Facts & Figures by Country
3.4.1 North America OTC Skin Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America OTC Skin Medicine Sales by Country (2019-2030)
3.4.3 North America OTC Skin Medicine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe OTC Skin Medicine Market Facts & Figures by Country
3.5.1 Europe OTC Skin Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe OTC Skin Medicine Sales by Country (2019-2030)
3.5.3 Europe OTC Skin Medicine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific OTC Skin Medicine Market Facts & Figures by Country
3.6.1 Asia Pacific OTC Skin Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific OTC Skin Medicine Sales by Country (2019-2030)
3.6.3 Asia Pacific OTC Skin Medicine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America OTC Skin Medicine Market Facts & Figures by Country
3.7.1 Latin America OTC Skin Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America OTC Skin Medicine Sales by Country (2019-2030)
3.7.3 Latin America OTC Skin Medicine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa OTC Skin Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa OTC Skin Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa OTC Skin Medicine Sales by Country (2019-2030)
3.8.3 Middle East and Africa OTC Skin Medicine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global OTC Skin Medicine Sales by Type (2019-2030)
4.1.1 Global OTC Skin Medicine Sales by Type (2019-2024)
4.1.2 Global OTC Skin Medicine Sales by Type (2025-2030)
4.1.3 Global OTC Skin Medicine Sales Market Share by Type (2019-2030)
4.2 Global OTC Skin Medicine Revenue by Type (2019-2030)
4.2.1 Global OTC Skin Medicine Revenue by Type (2019-2024)
4.2.2 Global OTC Skin Medicine Revenue by Type (2025-2030)
4.2.3 Global OTC Skin Medicine Revenue Market Share by Type (2019-2030)
4.3 Global OTC Skin Medicine Price by Type (2019-2030)
5 Segment by Application
5.1 Global OTC Skin Medicine Sales by Application (2019-2030)
5.1.1 Global OTC Skin Medicine Sales by Application (2019-2024)
5.1.2 Global OTC Skin Medicine Sales by Application (2025-2030)
5.1.3 Global OTC Skin Medicine Sales Market Share by Application (2019-2030)
5.2 Global OTC Skin Medicine Revenue by Application (2019-2030)
5.2.1 Global OTC Skin Medicine Revenue by Application (2019-2024)
5.2.2 Global OTC Skin Medicine Revenue by Application (2025-2030)
5.2.3 Global OTC Skin Medicine Revenue Market Share by Application (2019-2030)
5.3 Global OTC Skin Medicine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer OTC Skin Medicine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer OTC Skin Medicine Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK OTC Skin Medicine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK OTC Skin Medicine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Teva
6.3.1 Teva Corporation Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva OTC Skin Medicine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Teva OTC Skin Medicine Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson OTC Skin Medicine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Johnson & Johnson OTC Skin Medicine Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Corporation Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis OTC Skin Medicine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Novartis OTC Skin Medicine Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Viatris
6.6.1 Viatris Corporation Information
6.6.2 Viatris Description and Business Overview
6.6.3 Viatris OTC Skin Medicine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Viatris OTC Skin Medicine Product Portfolio
6.6.5 Viatris Recent Developments/Updates
6.7 Sun Pharmaceutical
6.6.1 Sun Pharmaceutical Corporation Information
6.6.2 Sun Pharmaceutical Description and Business Overview
6.6.3 Sun Pharmaceutical OTC Skin Medicine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sun Pharmaceutical OTC Skin Medicine Product Portfolio
6.7.5 Sun Pharmaceutical Recent Developments/Updates
6.8 China Resources Sanjiu Pharmaceutical
6.8.1 China Resources Sanjiu Pharmaceutical Corporation Information
6.8.2 China Resources Sanjiu Pharmaceutical Description and Business Overview
6.8.3 China Resources Sanjiu Pharmaceutical OTC Skin Medicine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 China Resources Sanjiu Pharmaceutical OTC Skin Medicine Product Portfolio
6.8.5 China Resources Sanjiu Pharmaceutical Recent Developments/Updates
6.9 HAPHARM GROUP
6.9.1 HAPHARM GROUP Corporation Information
6.9.2 HAPHARM GROUP Description and Business Overview
6.9.3 HAPHARM GROUP OTC Skin Medicine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 HAPHARM GROUP OTC Skin Medicine Product Portfolio
6.9.5 HAPHARM GROUP Recent Developments/Updates
6.10 Zhejiang DND PHARMACEUTICAL
6.10.1 Zhejiang DND PHARMACEUTICAL Corporation Information
6.10.2 Zhejiang DND PHARMACEUTICAL Description and Business Overview
6.10.3 Zhejiang DND PHARMACEUTICAL OTC Skin Medicine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Zhejiang DND PHARMACEUTICAL OTC Skin Medicine Product Portfolio
6.10.5 Zhejiang DND PHARMACEUTICAL Recent Developments/Updates
6.11 Winsun
6.11.1 Winsun Corporation Information
6.11.2 Winsun OTC Skin Medicine Description and Business Overview
6.11.3 Winsun OTC Skin Medicine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Winsun OTC Skin Medicine Product Portfolio
6.11.5 Winsun Recent Developments/Updates
6.12 Dinuo Pharmaceutical
6.12.1 Dinuo Pharmaceutical Corporation Information
6.12.2 Dinuo Pharmaceutical OTC Skin Medicine Description and Business Overview
6.12.3 Dinuo Pharmaceutical OTC Skin Medicine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Dinuo Pharmaceutical OTC Skin Medicine Product Portfolio
6.12.5 Dinuo Pharmaceutical Recent Developments/Updates
6.13 Guizhou Finder Phar maceutical
6.13.1 Guizhou Finder Phar maceutical Corporation Information
6.13.2 Guizhou Finder Phar maceutical OTC Skin Medicine Description and Business Overview
6.13.3 Guizhou Finder Phar maceutical OTC Skin Medicine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Guizhou Finder Phar maceutical OTC Skin Medicine Product Portfolio
6.13.5 Guizhou Finder Phar maceutical Recent Developments/Updates
6.14 Nanjing Cuccess Pharmaceutical
6.14.1 Nanjing Cuccess Pharmaceutical Corporation Information
6.14.2 Nanjing Cuccess Pharmaceutical OTC Skin Medicine Description and Business Overview
6.14.3 Nanjing Cuccess Pharmaceutical OTC Skin Medicine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Nanjing Cuccess Pharmaceutical OTC Skin Medicine Product Portfolio
6.14.5 Nanjing Cuccess Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 OTC Skin Medicine Industry Chain Analysis
7.2 OTC Skin Medicine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 OTC Skin Medicine Production Mode & Process
7.4 OTC Skin Medicine Sales and Marketing
7.4.1 OTC Skin Medicine Sales Channels
7.4.2 OTC Skin Medicine Distributors
7.5 OTC Skin Medicine Customers
8 OTC Skin Medicine Market Dynamics
8.1 OTC Skin Medicine Industry Trends
8.2 OTC Skin Medicine Market Drivers
8.3 OTC Skin Medicine Market Challenges
8.4 OTC Skin Medicine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global OTC Skin Medicine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global OTC Skin Medicine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global OTC Skin Medicine Market Competitive Situation by Manufacturers in 2023
Table 4. Global OTC Skin Medicine Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global OTC Skin Medicine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global OTC Skin Medicine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global OTC Skin Medicine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market OTC Skin Medicine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of OTC Skin Medicine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of OTC Skin Medicine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of OTC Skin Medicine, Product Type & Application
Table 12. Global Key Manufacturers of OTC Skin Medicine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global OTC Skin Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Skin Medicine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global OTC Skin Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global OTC Skin Medicine Sales by Region (2019-2024) & (K Units)
Table 18. Global OTC Skin Medicine Sales Market Share by Region (2019-2024)
Table 19. Global OTC Skin Medicine Sales by Region (2025-2030) & (K Units)
Table 20. Global OTC Skin Medicine Sales Market Share by Region (2025-2030)
Table 21. Global OTC Skin Medicine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global OTC Skin Medicine Revenue Market Share by Region (2019-2024)
Table 23. Global OTC Skin Medicine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global OTC Skin Medicine Revenue Market Share by Region (2025-2030)
Table 25. North America OTC Skin Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America OTC Skin Medicine Sales by Country (2019-2024) & (K Units)
Table 27. North America OTC Skin Medicine Sales by Country (2025-2030) & (K Units)
Table 28. North America OTC Skin Medicine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America OTC Skin Medicine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe OTC Skin Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe OTC Skin Medicine Sales by Country (2019-2024) & (K Units)
Table 32. Europe OTC Skin Medicine Sales by Country (2025-2030) & (K Units)
Table 33. Europe OTC Skin Medicine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe OTC Skin Medicine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific OTC Skin Medicine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific OTC Skin Medicine Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific OTC Skin Medicine Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific OTC Skin Medicine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific OTC Skin Medicine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America OTC Skin Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America OTC Skin Medicine Sales by Country (2019-2024) & (K Units)
Table 42. Latin America OTC Skin Medicine Sales by Country (2025-2030) & (K Units)
Table 43. Latin America OTC Skin Medicine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America OTC Skin Medicine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa OTC Skin Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa OTC Skin Medicine Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa OTC Skin Medicine Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa OTC Skin Medicine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa OTC Skin Medicine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global OTC Skin Medicine Sales (K Units) by Type (2019-2024)
Table 51. Global OTC Skin Medicine Sales (K Units) by Type (2025-2030)
Table 52. Global OTC Skin Medicine Sales Market Share by Type (2019-2024)
Table 53. Global OTC Skin Medicine Sales Market Share by Type (2025-2030)
Table 54. Global OTC Skin Medicine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global OTC Skin Medicine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global OTC Skin Medicine Revenue Market Share by Type (2019-2024)
Table 57. Global OTC Skin Medicine Revenue Market Share by Type (2025-2030)
Table 58. Global OTC Skin Medicine Price (US$/Unit) by Type (2019-2024)
Table 59. Global OTC Skin Medicine Price (US$/Unit) by Type (2025-2030)
Table 60. Global OTC Skin Medicine Sales (K Units) by Application (2019-2024)
Table 61. Global OTC Skin Medicine Sales (K Units) by Application (2025-2030)
Table 62. Global OTC Skin Medicine Sales Market Share by Application (2019-2024)
Table 63. Global OTC Skin Medicine Sales Market Share by Application (2025-2030)
Table 64. Global OTC Skin Medicine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global OTC Skin Medicine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global OTC Skin Medicine Revenue Market Share by Application (2019-2024)
Table 67. Global OTC Skin Medicine Revenue Market Share by Application (2025-2030)
Table 68. Global OTC Skin Medicine Price (US$/Unit) by Application (2019-2024)
Table 69. Global OTC Skin Medicine Price (US$/Unit) by Application (2025-2030)
Table 70. Bayer Corporation Information
Table 71. Bayer Description and Business Overview
Table 72. Bayer OTC Skin Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Bayer OTC Skin Medicine Product
Table 74. Bayer Recent Developments/Updates
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK OTC Skin Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. GSK OTC Skin Medicine Product
Table 79. GSK Recent Developments/Updates
Table 80. Teva Corporation Information
Table 81. Teva Description and Business Overview
Table 82. Teva OTC Skin Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Teva OTC Skin Medicine Product
Table 84. Teva Recent Developments/Updates
Table 85. Johnson & Johnson Corporation Information
Table 86. Johnson & Johnson Description and Business Overview
Table 87. Johnson & Johnson OTC Skin Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Johnson & Johnson OTC Skin Medicine Product
Table 89. Johnson & Johnson Recent Developments/Updates
Table 90. Novartis Corporation Information
Table 91. Novartis Description and Business Overview
Table 92. Novartis OTC Skin Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Novartis OTC Skin Medicine Product
Table 94. Novartis Recent Developments/Updates
Table 95. Viatris Corporation Information
Table 96. Viatris Description and Business Overview
Table 97. Viatris OTC Skin Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Viatris OTC Skin Medicine Product
Table 99. Viatris Recent Developments/Updates
Table 100. Sun Pharmaceutical Corporation Information
Table 101. Sun Pharmaceutical Description and Business Overview
Table 102. Sun Pharmaceutical OTC Skin Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Sun Pharmaceutical OTC Skin Medicine Product
Table 104. Sun Pharmaceutical Recent Developments/Updates
Table 105. China Resources Sanjiu Pharmaceutical Corporation Information
Table 106. China Resources Sanjiu Pharmaceutical Description and Business Overview
Table 107. China Resources Sanjiu Pharmaceutical OTC Skin Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. China Resources Sanjiu Pharmaceutical OTC Skin Medicine Product
Table 109. China Resources Sanjiu Pharmaceutical Recent Developments/Updates
Table 110. HAPHARM GROUP Corporation Information
Table 111. HAPHARM GROUP Description and Business Overview
Table 112. HAPHARM GROUP OTC Skin Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. HAPHARM GROUP OTC Skin Medicine Product
Table 114. HAPHARM GROUP Recent Developments/Updates
Table 115. Zhejiang DND PHARMACEUTICAL Corporation Information
Table 116. Zhejiang DND PHARMACEUTICAL Description and Business Overview
Table 117. Zhejiang DND PHARMACEUTICAL OTC Skin Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Zhejiang DND PHARMACEUTICAL OTC Skin Medicine Product
Table 119. Zhejiang DND PHARMACEUTICAL Recent Developments/Updates
Table 120. Winsun Corporation Information
Table 121. Winsun Description and Business Overview
Table 122. Winsun OTC Skin Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Winsun OTC Skin Medicine Product
Table 124. Winsun Recent Developments/Updates
Table 125. Dinuo Pharmaceutical Corporation Information
Table 126. Dinuo Pharmaceutical Description and Business Overview
Table 127. Dinuo Pharmaceutical OTC Skin Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Dinuo Pharmaceutical OTC Skin Medicine Product
Table 129. Dinuo Pharmaceutical Recent Developments/Updates
Table 130. Guizhou Finder Phar maceutical Corporation Information
Table 131. Guizhou Finder Phar maceutical Description and Business Overview
Table 132. Guizhou Finder Phar maceutical OTC Skin Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Guizhou Finder Phar maceutical OTC Skin Medicine Product
Table 134. Guizhou Finder Phar maceutical Recent Developments/Updates
Table 135. Nanjing Cuccess Pharmaceutical Corporation Information
Table 136. Nanjing Cuccess Pharmaceutical Description and Business Overview
Table 137. Nanjing Cuccess Pharmaceutical OTC Skin Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Nanjing Cuccess Pharmaceutical OTC Skin Medicine Product
Table 139. Nanjing Cuccess Pharmaceutical Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. OTC Skin Medicine Distributors List
Table 143. OTC Skin Medicine Customers List
Table 144. OTC Skin Medicine Market Trends
Table 145. OTC Skin Medicine Market Drivers
Table 146. OTC Skin Medicine Market Challenges
Table 147. OTC Skin Medicine Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of OTC Skin Medicine
Figure 2. Global OTC Skin Medicine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global OTC Skin Medicine Market Share by Type in 2023 & 2030
Figure 4. Oral Product Picture
Figure 5. Topical Product Picture
Figure 6. Global OTC Skin Medicine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global OTC Skin Medicine Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Drug Store
Figure 10. Online Supermarket
Figure 11. Others
Figure 12. Global OTC Skin Medicine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global OTC Skin Medicine Market Size (2019-2030) & (US$ Million)
Figure 14. Global OTC Skin Medicine Sales (2019-2030) & (K Units)
Figure 15. Global OTC Skin Medicine Average Price (US$/Unit) & (2019-2030)
Figure 16. OTC Skin Medicine Report Years Considered
Figure 17. OTC Skin Medicine Sales Share by Manufacturers in 2023
Figure 18. Global OTC Skin Medicine Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest OTC Skin Medicine Players: Market Share by Revenue in 2023
Figure 20. OTC Skin Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global OTC Skin Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America OTC Skin Medicine Sales Market Share by Country (2019-2030)
Figure 23. North America OTC Skin Medicine Revenue Market Share by Country (2019-2030)
Figure 24. United States OTC Skin Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada OTC Skin Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe OTC Skin Medicine Sales Market Share by Country (2019-2030)
Figure 27. Europe OTC Skin Medicine Revenue Market Share by Country (2019-2030)
Figure 28. Germany OTC Skin Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France OTC Skin Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. OTC Skin Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy OTC Skin Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Netherlands OTC Skin Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific OTC Skin Medicine Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific OTC Skin Medicine Revenue Market Share by Region (2019-2030)
Figure 35. China OTC Skin Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan OTC Skin Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea OTC Skin Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India OTC Skin Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Southeast Asia OTC Skin Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan OTC Skin Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia OTC Skin Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America OTC Skin Medicine Sales Market Share by Country (2019-2030)
Figure 43. Latin America OTC Skin Medicine Revenue Market Share by Country (2019-2030)
Figure 44. Mexico OTC Skin Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil OTC Skin Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina OTC Skin Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa OTC Skin Medicine Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa OTC Skin Medicine Revenue Market Share by Country (2019-2030)
Figure 49. Turkey OTC Skin Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia OTC Skin Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE OTC Skin Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of OTC Skin Medicine by Type (2019-2030)
Figure 53. Global Revenue Market Share of OTC Skin Medicine by Type (2019-2030)
Figure 54. Global OTC Skin Medicine Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of OTC Skin Medicine by Application (2019-2030)
Figure 56. Global Revenue Market Share of OTC Skin Medicine by Application (2019-2030)
Figure 57. Global OTC Skin Medicine Price (US$/Unit) by Application (2019-2030)
Figure 58. OTC Skin Medicine Value Chain
Figure 59. OTC Skin Medicine Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
